Download PDF
Thromb Haemost 1996; 76(04): 492-499
DOI: 10.1055/s-0038-1650609
Review Article
Schattauer GmbH Stuttgart

Coagulation Factor VII, Dietary Fat and Blood Lipids: A Review[*]

L I Mennen
1   The Department of Epidemiology and Biostatistics, Erasmus University Medical School, Rotterdam, The Netherlands
2   Department of Epidemiology and Public Health, Agricultural University Wageningen, Wageningen, The Netherlands
,
E G Schouten
2   Department of Epidemiology and Public Health, Agricultural University Wageningen, Wageningen, The Netherlands
,
D E Grobbee
1   The Department of Epidemiology and Biostatistics, Erasmus University Medical School, Rotterdam, The Netherlands
,
C Kluft
3   Gaubius Laboratory TNO-PG, Leiden, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 07 November 1995

Accepted after resubmission 21 June 1996

Publication Date:
10 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

* This work was supported by a grant from the Dutch Organization of Scientific Research (No. 904-61-076)


 

  • References

  • 1 Meade TW, Brozović M, Chakrabarti RR. et al Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. The Lancet 1986; 06: 533-537
    PubMedGoogle Scholar
  • 2 Ruddock V, Meade TW. Factor VII activity and ischaemic heart disease: fatal and non-fatal events. Q J Med 1994; 87: 403-406
    PubMedGoogle Scholar
  • 3 Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb 1994; 14: 54-59
    CrossrefPubMedGoogle Scholar
  • 4 Miller GJ, Stirling Y, Esnouf MP. et al Factor VH-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study. Thromb Haemost 1994; 71: 38-48
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Miller GJ, Martin JC, Mitropoulos KA. et al Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition. Atherosclerosis 1991; 86: 163-71
    CrossrefPubMedGoogle Scholar
  • 6 Folsom AR, Wu KK, Shahar E, Davis CE. Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. Arterioscler Thromb 1993; 13: 1829-36
    CrossrefPubMedGoogle Scholar
  • 7 Broadhurst P, Kelleher C, Hughes L, Imeson JD, Raftery EB. Fibrinogen factor VII clotting activity and coronary artery disease severity. Atherosclerosis 1990; 85: 169-73
    CrossrefPubMedGoogle Scholar
  • 8 Carvalho de Sousa J, Azevedo J, Soria C. Factor VII hyperactivation in acute myocardial thrombosis. A relation to the coagulation activation. Thromb Res 1988; 51: 165-173
    CrossrefPubMedGoogle Scholar
  • 9 Hoffman CJ, Miller RH, Lawson WE, Hultin MB. Elevation of factor VII activity and mass in young adults at risk of ischemic heart disease. J Am Coll Cardiol 1989; 14: 941-946
    CrossrefPubMedGoogle Scholar
  • 10 Hoffman CJ, Bums P, Lawson WE, Katz JP, Miller RH, Hultin MB. Plasma fibrinogen level is not elevated in young adults from families with premature ischemic heart disease. Arterioscler Thromb 1993; 13: 800-3
    CrossrefPubMedGoogle Scholar
  • 11 Hoffman C, Shah A, Sodums M, Hultin MB. Factor VII activity state in coronary artery disease. J Lab Clin Med 1988; 111: 475-81
    PubMedGoogle Scholar
  • 12 Suzuki T, Yamauchi K, Matsusita T. et al Elevation of factor VII activity and mass in coronary artery disease of varying severity. Clin Cardiol 1991; 14: 731-736
    CrossrefPubMedGoogle Scholar
  • 13 Wu KK, Folsom AR, Heiss G, Davisx CE, Conlan MG, Barnes R. Association of coagulation factors and inhibitors with carotid artery atherosclerosis. Early results of the atherosclerosis risk in communities (ARIC) study. Ann Epidemiol 1992; 4: 471-480
    PubMedGoogle Scholar
  • 14 Sosef MN, Bosch JG, Oostayen Jvan, Visser T, Reiber JHC, Rosendaal FR. Relation of plasma coagulation factor VII and fibrinogen to carotid artery intima-media thickness. Thromb Haemost 1994; 72: 250-254
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Balleisen L, Bailey J, Epping PH, Schulte H, Loo Jvan de. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using and menopause. Thromb Haemost 1985; 54: 475-479
    PubMedGoogle Scholar
  • 16 Miller GJ, Cruickshank JK, Ellis LJ. et al Fat consumption and factor VII coagulant activity in middle-aged men. An association between a dietary and thrombogenic coronary risk factor. Atherosclerosis 1989; 78: 19-24
    CrossrefPubMedGoogle Scholar
  • 17 Marckmann P, Sandström B, Jespersen J. Effects of total fat content and fatty acid composition in diet on factor VII coagulant activity and blood lipids. Atherosclerosis 1990; 80: 227-233
    CrossrefPubMedGoogle Scholar
  • 18 Heinrich J, Wahrburg U, Marting H, Assmann G. The effect of diets, rich in mono-or polyunsaturated fatty acids, on lipid metabolism and haemostasis. Fibrinolysis 1990; 4: 76-78
    PubMedGoogle Scholar
  • 19 Folsom AR, Conlan MG, Davis CE, Wu KK. Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults. Ann Epidemiol 1992; 4: 481-94
    PubMedGoogle Scholar
  • 20 Bruckert E, Carvalho de Sousa J, Giral P. et al Interrelationships of plasma triglyceride and coagulant factor VII levels in normotriglyceridemic hypercholesterolemia. Atherosclerosis 1989; 75: 129-34
    CrossrefPubMedGoogle Scholar
  • 21 Carvalho de Sous J, Bruckert E, Giral P. et al Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible mechanism of factor VII hyperactivity. Haemostasis 1989; 19: 125-30
    PubMedGoogle Scholar
  • 22 Green F, Kelleher C, Wilkes H, Temple A, Meade T, Humphries S. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb 1991; 11: 540-546
    CrossrefPubMedGoogle Scholar
  • 23 Lane A, Cruickshank JK, Mitchell J, Henderson A, Humphries S, Green F. Genetic and environmental determinants of factor VII coagulant activity inethnic groups at differing risk of coronary heart disease. Atherosclerosis 1992; 94: 43-50
    CrossrefPubMedGoogle Scholar
  • 24 Humphries SE, Lane A, Green FR, Cooper J, Miller GJ. Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration. Arterioscler Thromb 1994; 14: 193-198
    CrossrefPubMedGoogle Scholar
  • 25 Fuller JH, Keen H, Jarret RJ. et al Haemostatic variables associated with diabetes and its complications. Br Med J 1979; 02: 964-6
    CrossrefPubMedGoogle Scholar
  • 26 Morrissey JH, Macik BG, Neuenschwander PF, Comp PC. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 1993; 81: 734-744
    PubMedGoogle Scholar
  • 27 Kitchen S, Malia RG, Preston FE. A comparison of methods for the measurement of activated factor VII. Thromb Haemost 1992; 68: 301-305
    Article in Thieme ConnectPubMedGoogle Scholar
  • 28 Poggio M, Tripodi A, Mariani G, Mannucciy PM. Factor VII Clotting assay: influence of different thromboplastins and factor VH-deficient plasmas. Thromb Haemost 1991; 65: 160-164
    Article in Thieme ConnectPubMedGoogle Scholar
  • 29 Deijk WA, Dam-Mieras MCEvan, Muller D, Hemker HC. Evaluation of a coagulation assay determining the activity state of factor VII in plasma. Haemostasis 1983; 13: 192-197
    PubMedGoogle Scholar
  • 30 Hemker HC, Muller AD, Gonggrijp R. The estimation of activated human blood coagulation factor VII. J Molecular Med 1976; 1: 127-134
    PubMedGoogle Scholar
  • 31 Messmore HL, Koza M, Hoppensteadt D, Blakemore C, Walenga J. Results of factor VII assays in adults with vascular disease are dependent upon several variables. Thromb Haemost 1991; 65: 909
    PubMedGoogle Scholar
  • 32 Østerud B. How to measure factor VII and factor VII activation. Haemostasis 1983; 13: 161-8
    PubMedGoogle Scholar
  • 33 Carvalho de Sousa J, Soria C, Ayrault-Jarrier M. et al Association between coagulation factors VII and X with triglyceride rich lipoproteins. J Clin Pathol 1988; 41: 940-944
    CrossrefPubMedGoogle Scholar
  • 34 Bladbjerg EM, Tholstrup T, Marckmann P, Sandström B, Jespersen J. Dietary changes in fasting levels of factor VII coagulant activity (FVILC)are accompanied by changes in factor VII protein and other vitamin K-dependent proteins. Thromb Haemost 1995; 73: 239-242
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Miller GJ. Hyperlipidaemia and hypercoagulability. Prog Lipid Res 1993; 32: 61-69
    CrossrefPubMedGoogle Scholar
  • 36 Mitropoulos KA, Esnouf MP. The prothrombin activation peptide regulates synthesis of the vitamin K-dependent proteins in the rabbit. Thromb Res 1990; 57: 541-549
    CrossrefPubMedGoogle Scholar
  • 37 Hoffman CJ, Lawson WE, Miller RH, Hultin MB. Correlation of vitamin K-dependent clotting factors with cholesterol and triglycerides in healthy young adults. Arterioscler Thromb 1994; 14: 1737-1740
    CrossrefPubMedGoogle Scholar
  • 38 Mitropoulos KA, Miller GJ, Reeves BEA, Wilkes HC, Cruickshank JK. Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoproteins particles in middle aged men. Atherosclerosis 1989; 76: 203-208
    CrossrefPubMedGoogle Scholar
  • 39 Mitropoulos KA, Martin JC, Reeves BEA, Esnouf MP. The activation of the contact phase of coagulation by physiologic surfaces in plasma: the effect of large negatively charged liposomal vesicles. Blood 1989; 73: 1525-1533
    PubMedGoogle Scholar
  • 40 Mitropoulos KA, Reeves BEA, Miller GJ. The activation of factor VII in citrated plasma by charged long-chain saturated fatty acids at the interface of large triglyceride-rich lipoproteins. Blood Coagul Fibrinol 1993; 04: 943-951
    CrossrefPubMedGoogle Scholar
  • 41 Mitropoulos KA, Miller GJ, Watts GF, Durrington PN. Lipolysis of triglyceride-rich lipoproteins activates coagulant factor VII: a study in familial lipoprotein-lipase deficiency. Atherosclerosis 1992; 95: 119-125
    CrossrefPubMedGoogle Scholar
  • 42 Marckmann P, Sandström B, Jespersen J. Fasting blood coagulation and fibrinolysis of young adults unchanged by reduction in dietary fat content. Arterioscler Thromb 1992; 12: 201-205
    CrossrefPubMedGoogle Scholar
  • 43 Marckmann P, Sandström B, Jespersen J. Low-fat, high-fiber diet favorably affects several independent risk markers of ischemic heart disease: observations on blood lipids, coagulation, and fibrinolysis from a trial of middle-aged Danes. Am J Clin Nutr 1994; 59: 935-936
    CrossrefPubMedGoogle Scholar
  • 44 Miller GJ, Martin JC, Webster J. et al Association between dietary fat intake and plasma factor VII coagulant activity - A predictor of cardiovascular mortality. Atherosclerosis 1986; 60: 269-77
    CrossrefPubMedGoogle Scholar
  • 45 Marckmann P, Sandström B, Jespersen J. Favorable long-term effect of a low-fat/high-fiber diet on human blood coagulation and fibrinolysis. Arterioscler Thromb 1993; 13: 505-511
    CrossrefPubMedGoogle Scholar
  • 46 Brace LD, Gittler-Buffa C, Miller GJ. et al Factor VII coagulant activity and cholesterol changes in premenopausal women consuming a long-term cholesterol-lowering diet. Arterioscler Thromb 1994; 14: 1282-1289
    PubMedGoogle Scholar
  • 47 Pekkanen J, Mutanen M, Rasanen L, Rauramaa R, Nissinen A. Association of factor VIIc activity with dietary fat and blood lipids among elderly men - The Finnish cohorts of The Seven Countries Study. Nutr Metab Cardiovasc Dis 1995; 5: 149-54
    PubMedGoogle Scholar
  • 48 Miller GJ, Stirling Y, Howarth DJ. et al Dietary fat intake and plasma factor VII antigen concentration. Thromb Haemost 1995; 73: 893
    Article in Thieme ConnectPubMedGoogle Scholar
  • 49 Tholstrup T, Marckmann P, Jespersen J, Sandström B. Fat high in stearic acid favorably affects blood lipids and factor VII coagulant activity in comparison with fats high in palmitic or high in myristic and lauric acids. Am J Clin Nutr 1994; 59: 371-377
    CrossrefPubMedGoogle Scholar
  • 50 Foley M, Ball M, Chisholm A, Duncan A, Spears G, Mann J. Should mono- or poly-unsaturated fats replace saturated fat in the diet?. Eur J Clin Nutr 1992; 46: 429-436
    PubMedGoogle Scholar
  • 51 Tholstrup T, Marckmann P, Jespersen J, Vessby B, Jart A, Sandström B. Effect on blood lipids, coagulation, and fibrinolysis of a fat high in myristic acid and a fat high in palmitic acid. Am J Clin Nutr 1994; 60: 919-925
    CrossrefPubMedGoogle Scholar
  • 52 Rankinen T, Rauramaa R, Väisänen S, Halonen P, Penttilä IM. Blood coagulation and fibrinolytic factors are unchanged by aerobic exercise or fat modified diet. Fibrinolysis 1994; 8: 48-53
    PubMedGoogle Scholar
  • 53 Hendra TJ, Britton ME, Roper DR. Effects of fish oil supplements in NIDDM subjects. Diabetes Care 1990; 13: 821-829
    CrossrefPubMedGoogle Scholar
  • 54 Shahar E, Folsom AR, Wu KK. et al Associations of fish intake and dietary n-3 polyunsaturated fatty acids with a hypocoagulable profile. Arterioscler Thromb 1993; 13: 1205-1212
    CrossrefPubMedGoogle Scholar
  • 55 Schmidt EB, Lervang HH, Vanning K, Madsen P, Dyerberg J. Long-term supplementation with n-3 fatty acids. I: Effect on blood lipids, haemostasis and blood pressure. Scand J Clin Lab Invest 1992; 53: 221-228
    PubMedGoogle Scholar
  • 56 Marckmann P, Jespersen J, Leth T, Sandström B. Effect of fish diet versus meat diet on blood lipids, coagulation and fibrinolysis in healthy young men. JInt Med 1991; 229: 317-323
    PubMedGoogle Scholar
  • 57 Lervang HH, Schmidt EB, Mpller J. et al The effect of low-dose supplementation with n-3 polyunsaturated fatty acids on some risk markers of coronary heart disease. Scand J Clin Lab Invest 1993; 53: 417-423
    CrossrefPubMedGoogle Scholar
  • 58 Muller AD, Houwelingen ACvan, Dam-Mieras MCEvan, Bas BM, Hornstra G. Effect of a moderate fish intake on haemostatic parameters in healthy males. Thromb Haemost 1989; 61: 468-473
    Article in Thieme ConnectPubMedGoogle Scholar
  • 59 Brown AJ, Roberts DCK. Fish and fish oil intake: effect on hematological variables related to cardiovascular disease. Thromb Res 1991; 64: 169-178
    CrossrefPubMedGoogle Scholar
  • 60 Berg-Schmidt E, Varming K, Ernst E, Madsen P, Dyerberg J. Dose-response studies on the effect of n-3 polyunsaturated fatty acids on lipids and haemostasis. Thromb Haemost 1990; 63: 1-5
    Article in Thieme ConnectPubMedGoogle Scholar
  • 61 Nordøy A, Hatcher L, Goodnight S, Fitzgerals GA, Connor WE. Effects of dietary fat content, saturated fatty acids, and fish oil on eicosanoid production and hemostatic parameters in normal men. J Lab Clin Med 1994; 123: 914-920
    PubMedGoogle Scholar
  • 62 Hornstra G. Effect of fish oil feeding on arterial trhombosis, platelet function and blood coagulation. In: Dietary Fats, Prostanods and arterial thrombosis Martinus Nijhoff Publishers; The Hague: 1982: 106-137
    Google Scholar
  • 63 Marckmann P, Sandström S, Jespersen J. Dietary effects on circadian fluctuation in human blood coagulation factor VII and fibrinolysis. Atherosclerosis 1993; 102: 225-34
    PubMedGoogle Scholar
  • 64 Bladbjerg EM, Marckmann P, Sandström B, Jespersen J. Non-fasting factor VII coagulant activity (FVII:C) increased by high-fat diet. Thromb Haemost 1994; 71: 755-788
    Article in Thieme ConnectPubMedGoogle Scholar
  • 65 Silveira A, Karpe F, Blombäcky M, Steiner G, Walldius G, Hamsten A. Activation of coagulation factor VII during alimentary lipemia. Arterioscler Thromb 1994; 14: 60-69
    CrossrefPubMedGoogle Scholar
  • 66 Moor E, Hamsten A, Karpe F, Båvenholm P, Blombäck M, Silveira A. Relationship of tissue factor pathway inhibitor activity to plasma lipoproteins and myocardial infarction at a young age. Thromb Haemost 1994; 71: 707-712
    Article in Thieme ConnectPubMedGoogle Scholar
  • 67 Salomaa V, Rasi V, Pekkanen J. et al The effects of saturated fat and n-6 polyunsaturated fat on postprandial lipemia and hemostatic activity. Atherosclerosis 1993; 103: 1-11
    CrossrefPubMedGoogle Scholar
  • 68 Mitropoulos KA, Miller GJ, Martin JC, Reeves BEA, Cooper J. Dietary fat induces changes in factor VII coagulant activity through effects on plasma free stearic acid concentration. Arterioscler Thromb 1994; 14: 214-222
    CrossrefPubMedGoogle Scholar
  • 69 Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. The Lancet 1993; 342: 1076-1079
    CrossrefPubMedGoogle Scholar
  • 70 Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991; 91: 191-205
    CrossrefPubMedGoogle Scholar
  • 71 Kario K, Matsuo T, Kario T, Kobayashi H. Sex-related differences in the relationship between plasma factor VII levels and serum lipids, lipoproteins and apolipoproteins. Thromb Res 1991; 64: 69-73
    CrossrefPubMedGoogle Scholar
  • 72 Tervahauta M, Pekkanen J, Kivinen P. et al Prevalence of coronary heart disease and associated risk factors among elderly Finnish men in the Seven Countries Study. Atherosclerosis 1993; 104: 47-59
    CrossrefPubMedGoogle Scholar
  • 73 Wright D, Poller L, Thomson JM, Gowland E, Burrows GE. The interrelationship of factor VII and its activity state with plasma lipids in healthy male adults. Br J Haematol 1993; 85: 348-351
    CrossrefPubMedGoogle Scholar
  • 74 Elwood PC, Beswick AD, O’Brien JR, Yamell JWG, Layzell JC, Limb ES. Inter-relationships between haemostatic tests and the effects of some dietary determinants in the Caerphilly cohort of older men. Blood Coagulat Fibrinol 1993; 4: 529-536
    PubMedGoogle Scholar
  • 75 Negri M, Arigliano PL, Talamini G, Carlini S, Manzato F, Bonadonna G. Levels of plasma factor VII and factor VII activated forms as a function of plasma triglyceride levels. Atherosclerosis 1993; 99: 55-61
    CrossrefPubMedGoogle Scholar
  • 76 Marckmann P, SandstrÖm B, Jespersen J. The variability of and associations between measures of blood coagulation, fibrinolysis and blood lipids. Atherosclerosis 1992; 96: 235-244
    CrossrefPubMedGoogle Scholar
  • 77 Donders SHJ, Lustermans FAT, Wersch JWJvan. Coagulation factors and lipid composition of the blood in treated and untreated hypertensive patients. Scand J Clin Lab Invest 1993; 53: 179-186
    CrossrefPubMedGoogle Scholar
  • 78 Donders SHJ, Lustermans FAT, Wersch JWJvan. Glycometabolic control, lipids, and coagulation parameters in patients with non-insulin-dependent diabetes mellitus. Int J Clin Lab Res 1993; 23: 155-159
    CrossrefPubMedGoogle Scholar
  • 79 Hoffman CJ, Miller RH, Hultin MB. Correlation of factor VII activity and antigen with cholesterol and triglycerides in healthy young adults. Arterioscler Thromb 1992; 12: 267-270
    CrossrefPubMedGoogle Scholar
  • 80 Howard PR, Bovill EG, Pike J, Church WR, Tracy RP. Factor VII antigen levels in a healthy blood donor population. Thromb Haemost 1994; 72: 21-27
    PubMedGoogle Scholar
  • 81 Manolio TE, Ettinger WH, Tracy RP. et al Epidemiology of low cholesterol levels in older adults. Circulation 1993; 87: 728-737
    CrossrefPubMedGoogle Scholar
  • 82 Yang XC, Jing TY, Resnick LM, Phillips GB. Relation of hemostatic risk factors to other risk factors for coronary heart disease and to sex hormones in men. Arterioscler Thromb 1993; 13: 467-471
    CrossrefPubMedGoogle Scholar
  • 83 Fredricksson DS, Levy RI, Lees RS. Fat transport in lipoproteins. An integrated approach to mechanisms and disorders. N Engl J Med 1967; 276: 94-103
    CrossrefPubMedGoogle Scholar
  • 84 Carvalho de Sousa J, Bruckert E, Giral P. et al Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyper-lipidaemia: A clinical and laboratory study. Haemostasis 1989; 19: 83-90
    PubMedGoogle Scholar
  • 85 Avellone G, Garbo Vdi, Cordove R, Raneli G, Simone Rde, Bompiani GD. Fibrinolysis in hypertriglyceridaemic subjects in response to venous occlusion. Blood Coagulation and Fibrinolysis 1993; 4: 429-433
    CrossrefPubMedGoogle Scholar
  • 86 Kario K, Matsuo T. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis. Atherosclerosis 1993; 103: 131-138
    CrossrefPubMedGoogle Scholar
  • 87 Nordøy A, Illingworh DR, Connor WE, Goodnight S. Increased activity of factor VII and factor Vll-phospholipid complex measured using a normo-test system in subjects with hyperlipidaemia. Haemostasis 1990; 20: 65-72
    PubMedGoogle Scholar
  • 88 Saha N, Liu Y, Heng CK, Hong S, Low PS, sTay JSH. Association of factor VII genotype with plasma factor VII activityand antigen levels in healthy Indian adults and interaction with triglycerides. Arterioscler Thromb 1994; 14: 1923-1927
    CrossrefPubMedGoogle Scholar
  • 89 Silveira A, Green F, Karpe F, Blomback M, Humphries S, Hamsten A. Elevated levels of factor VII activity in the postprandial state: effect of the factor VII Arg-Gln polymorphism. Thromb Haemost 1994; 72: 734-739
    Article in Thieme ConnectPubMedGoogle Scholar
  • 90 Humphries SE, Lane A, Green FR, Cooper J, Miller GJ. Factor VII coagulant activity and antigen levels in healthy men are determined by interaction betweenfactor VII genotype and plasma triglyceride concentration. Arterioscler Thromb 1994; 14: 193-198
    CrossrefPubMedGoogle Scholar
  • 91 Weintraub MS, Zechner R, Brown A, Eisenberg S, Breslow JL. Dietary polyunsaturated fats ofthe w-6 and w-3 series reduce postprandial lipoprotein levels: chronicand acute effects of fat saturationon postprandial lipoprotein metabolism. J Clin Invest 1988; 82: 1884-1893
    CrossrefPubMedGoogle Scholar
  • 92 Harris WS. Fish oils and plasma lipid and lipoprotein metabolism in humans: Acritical review. J Lipid Res 1989; 30: 785-807
    PubMedGoogle Scholar